News
From the network
Milestones, firsts, and community work from across our sites. Refreshed monthly. Sponsor names and study identifiers stay confidential, always.
Milestone
First patient worldwide dosed in a Phase 2 angiokeratoma trial
One of our sites became the first in the world to enroll and dose a patient in a Phase 2 angiokeratoma study.
Read more →Milestone
A rare lupus randomization, among the first worldwide
In a global lupus study, Stryde delivered one of only a handful of randomizations achieved anywhere so far.
Read more →Milestone
First patient randomized in a groundbreaking skin cancer trial
Stryde randomized its first patient in a skin cancer study testing a new, less invasive injection-based treatment.
Read more →Community
Stryde at the Lupus & You Empowerment Conference
Our lupus team joined the Lupus Foundation of America's conference in Dallas to connect with patients and advocates.
Read more →